Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle
- PMID: 20730442
- DOI: 10.1007/s00417-010-1490-y
Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle
Abstract
Purpose: Intravitreal injections may lead to a significant elevation of the intraocular pressure (IOP). A paracentesis may become necessary for acute reduction of the IOP in certain cases. The purpose of this study was to determine the frequency of paracentesis performed and the grade of reflux under the conjunctiva after injection of 0.1 ml bevacizumab (1.25 mg), depending on the thickness of the needles used.
Methods: A retrospective review was undertaken of the surgery reports of 234 consecutive intravitreal bevacizumab injections in 145 eyes of 144 patients within 14 months. In particular, the frequency of paracentesis, the thickness of the needles used (27-gauge versus 30-gauge), the lens status, and a semi-quantitative reflux grade were analysed.
Results: A paracentesis was performed in 78 cases (33%) for acute reduction of the IOP. In the 27-gauge group the frequency was 26% (25 of 96), and in the 30-gauge group 38% (53 of 138) (p = 0.05, independent estimating equation (IEE)). The medians of the semi-quantitative assessment of the reflux grade under the conjunctiva were 2.0 in the 27-gauge group (corresponding to a mild reflux) and 1.0 in the 30-gauge group (corresponding to a minimal reflux, p < 0.001, IEE).
Conclusions: When using a 30-gauge needle for intravitreal injections, the reflux under the conjunctiva was less than with a 27-gauge needle. However, the use of a 30-gauge needle appeared to be associated with a higher frequency of paracentesis.
Similar articles
-
Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits.Arch Ophthalmol. 2010 Jul;128(7):884-7. doi: 10.1001/archophthalmol.2010.139. Arch Ophthalmol. 2010. PMID: 20625050
-
ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS.Retina. 2015 Jul;35(7):1401-6. doi: 10.1097/IAE.0000000000000476. Retina. 2015. PMID: 25650712
-
Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.Arch Ophthalmol. 2010 Dec;128(12):1523-7. doi: 10.1001/archophthalmol.2010.297. Arch Ophthalmol. 2010. PMID: 21149773
-
Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy.Curr Opin Ophthalmol. 2012 Mar;23(2):105-10. doi: 10.1097/ICU.0b013e32834ff41d. Curr Opin Ophthalmol. 2012. PMID: 22249237 Review.
-
Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents.Semin Ophthalmol. 2013 May;28(3):126-30. doi: 10.3109/08820538.2013.771195. Epub 2013 Apr 30. Semin Ophthalmol. 2013. PMID: 23631423 Review.
Cited by
-
Evaluation of intraocular pressure change and anterior segment parameters after intravitreal bevacizumab injection - Cannula size matters.Saudi J Ophthalmol. 2021 Jul 29;34(4):247-250. doi: 10.4103/1319-4534.322606. eCollection 2020 Oct-Dec. Saudi J Ophthalmol. 2021. PMID: 34527866 Free PMC article.
-
Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.Br J Ophthalmol. 2025 Apr 22;109(5):600-605. doi: 10.1136/bjo-2024-326053. Br J Ophthalmol. 2025. PMID: 39532510 Free PMC article.
-
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.BMJ Open. 2014 Jul 17;4(7):e005244. doi: 10.1136/bmjopen-2014-005244. BMJ Open. 2014. PMID: 25034629 Free PMC article.
-
Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity.Jpn J Ophthalmol. 2019 May;63(3):262-268. doi: 10.1007/s10384-019-00661-y. Epub 2019 Mar 1. Jpn J Ophthalmol. 2019. PMID: 30825009
-
Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects.Int J Retina Vitreous. 2019 Mar 6;5:8. doi: 10.1186/s40942-019-0157-z. eCollection 2019. Int J Retina Vitreous. 2019. PMID: 30873293 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources